S(-)rabeprazole compositions and methods
    6.
    发明申请
    S(-)rabeprazole compositions and methods 审中-公开
    S( - )雷贝拉唑组合物和方法

    公开(公告)号:US20050222211A1

    公开(公告)日:2005-10-06

    申请号:US11140675

    申请日:2005-05-27

    CPC分类号: A61K31/4439 A61K31/00

    摘要: Methods and compositions are disclosed utilizing optically pure S(−)rabeprazole for the treatment of ulcers in humans while substantially reducing the concomitant liability of adverse effects associated with the racemic mixture of rabeprazole. The optically pure S(−) isomer is also useful for the treatment of gastroesophageal reflux. S(−)rabeprazole is an inhibitor of H+ release and is therefore useful in the treatment of other conditions related to gastric hypersecretion such as Zollinger-Ellison Syndrome.

    摘要翻译: 公开了使用光学纯的S( - )雷贝拉唑治疗人体溃疡的方法和组合物,同时显着减少与雷贝拉唑的外消旋混合物相关的副作用的伴随的责任。 光学纯的S( - )异构体也可用于治疗胃食管反流。 S( - )雷贝拉唑是一种H +抑制剂,因此可用于治疗与胃分泌异常有关的其他病症,如Zollinger-Ellison综合征。